These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35341265)

  • 21. Genomic Surveillance Tracks the First Community Outbreak of the SARS-CoV-2 Delta (B.1.617.2) Variant in Brazil.
    Lamarca AP; de Almeida LGP; da Silva Francisco R; Cavalcante L; Machado DT; Brustolini O; Gerber AL; Guimarães APC; Policarpo C; Oliveira GDS; Boullosa LT; Souza IV; Carvalho EM; Ribeiro MS; Carvalho S; Silva FDD; Garcia MHO; Souza LM; Silva CGD; Ribeiro CLP; Cavalcanti AC; Mello CMB; Tanuri A; Vasconcelos ATR
    J Virol; 2022 Jan; 96(2):e0122821. PubMed ID: 34730387
    [No Abstract]   [Full Text] [Related]  

  • 22. SARS-CoV-2 Variants of Concern Increased Transmission and Decrease Vaccine Efficacy in the COVID-19 Pandemic in Palembang Indonesia.
    Ghiffari A; Anwar C; Hasyim H; Iskandar I; Kamaluddin MT
    Acta Biomed; 2022 Mar; 93(1):e2022018. PubMed ID: 35315393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.
    Choi A; Koch M; Wu K; Dixon G; Oestreicher J; Legault H; Stewart-Jones GBE; Colpitts T; Pajon R; Bennett H; Carfi A; Edwards DK
    J Virol; 2021 Nov; 95(23):e0131321. PubMed ID: 34549975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain.
    Fernández-Bastit L; Rodon J; Pradenas E; Marfil S; Trinité B; Parera M; Roca N; Pou A; Cantero G; Lorca-Oró C; Carrillo J; Izquierdo-Useros N; Clotet B; Noguera-Julián M; Blanco J; Vergara-Alert J; Segalés J
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and laboratory profiles of the SARS-CoV-2 Delta variant compared with pre-Delta variants.
    Bhakta S; Sanghavi DK; Johnson PW; Kunze KL; Neville MR; Wadei HM; Bosch W; Carter RE; Shah SZ; Pollock BD; Oman SP; Speicher L; Siegel J; Libertin CR; Matson MW; Moreno Franco P; Cowart JB
    Int J Infect Dis; 2022 Jul; 120():88-95. PubMed ID: 35487339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility - Oklahoma, April-May 2021.
    Dougherty K; Mannell M; Naqvi O; Matson D; Stone J
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(28):1004-1007. PubMed ID: 34264910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
    Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
    J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delta Variant: The New Challenge of COVID-19 Pandemic, an Overview of Epidemiological, Clinical, and Immune Characteristics.
    Samieefar N; Rashedi R; Akhlaghdoust M; Mashhadi M; Darzi P; Rezaei N
    Acta Biomed; 2022 Mar; 93(1):e2022179. PubMed ID: 35315394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Delta Variant among Asiatic Lions, India.
    Mishra A; Kumar N; Bhatia S; Aasdev A; Kanniappan S; Sekhar AT; Gopinadhan A; Silambarasan R; Sreekumar C; Dubey CK; Tripathi M; Raut AA; Singh VP
    Emerg Infect Dis; 2021 Oct; 27(10):2723-2725. PubMed ID: 34545805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 B.1.1.7 Decline Is Not Driven by the Introduction of a More Successful Variant.
    Rodríguez-Grande C; Buenestado-Serrano S; Alcalá L; Sola-Campoy PJ; Molero-Salinas A; Otero-Sobrino Á; Rodríguez-Grande J; de la Cueva García VM; Adán-Jiménez J; Rico-Luna C; Losada C; Catalán P; Muñoz P; Pérez-Lago L; García de Viedma D;
    Microbiol Spectr; 2021 Dec; 9(3):e0112821. PubMed ID: 34787494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An entropy-based study on mutational trajectory of SARS-CoV-2 in India.
    Santoni D; Ghosh N; Saha I
    Infect Genet Evol; 2022 Jan; 97():105154. PubMed ID: 34808395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021.
    Ghosh AK; Kaiser M; Molla MMA; Nafisa T; Yeasmin M; Ratul RH; Sharif MM; Akram A; Hosen N; Mamunur R; Amin MR; Islam A; Hoque ME; Landt O; Lytton SD
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA.
    Earnest R; Uddin R; Matluk N; Renzette N; Turbett SE; Siddle KJ; Loreth C; Adams G; Tomkins-Tinch CH; Petrone ME; Rothman JE; Breban MI; Koch RT; Billig K; Fauver JR; Vogels CBF; Bilguvar K; De Kumar B; Landry ML; Peaper DR; Kelly K; Omerza G; Grieser H; Meak S; Martha J; Dewey HB; Kales S; Berenzy D; Carpenter-Azevedo K; King E; Huard RC; Novitsky V; Howison M; Darpolor J; Manne A; Kantor R; Smole SC; Brown CM; Fink T; Lang AS; Gallagher GR; Pitzer VE; Sabeti PC; Gabriel S; MacInnis BL; ; Tewhey R; Adams MD; Park DJ; Lemieux JE; Grubaugh ND
    Cell Rep Med; 2022 Apr; 3(4):100583. PubMed ID: 35480627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OraSure InteliSwab
    Weishampel ZA; Young J; Fischl M; Fischer RJ; Donkor IO; Riopelle JC; Schulz JE; Port JR; Saturday TA; van Doremalen N; Berry JD; Munster VJ; Yinda CK
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.
    SeyedAlinaghi S; Mirzapour P; Dadras O; Pashaei Z; Karimi A; MohsseniPour M; Soleymanzadeh M; Barzegary A; Afsahi AM; Vahedi F; Shamsabadi A; Behnezhad F; Saeidi S; Mehraeen E; Shayesteh Jahanfar
    Eur J Med Res; 2021 Jun; 26(1):51. PubMed ID: 34103090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.
    Yu ALF; Liphaus BL; Ferreira PM; Tanamachi AT; Masuda ET; Trevisan CM; Lucas PCC; Bugno A; Carvalhanas TRMP
    Rev Inst Med Trop Sao Paulo; 2021; 63():e50. PubMed ID: 34161556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting the Trajectory of Replacements of SARS-CoV-2 Variants Using Relative Reproduction Numbers.
    Piantham C; Ito K
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of Novel SARS-CoV-2 variants in India: second wave.
    Adiga R; Nayak V
    J Infect Dev Ctries; 2021 Nov; 15(11):1578-1583. PubMed ID: 34898481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Early Pandemic SARS-CoV-2 Lineages Replacement with the Variant of Concern P.1 (Gamma) in Western Bahia, Brazil.
    Pinheiro JR; Dos Reis EC; Farias JP; Fogaça MMC; da Silva PS; Santana IVR; Rocha ALS; Vidal PO; Simões RDC; Luiz WB; Birbrair A; de Aguiar RS; de Souza RP; Azevedo VAC; Chaves G; Belmok A; Durães-Carvalho R; Melo FL; Ribeiro BM; Amorim JH
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.